We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Texas Compounder Warned for Sterility Practices, Other GMP Violations
Texas Compounder Warned for Sterility Practices, Other GMP Violations
The FDA issued a warning letter to a Texas drug compounding facility after it failed to resolve problems identified during an inspection, including serious deficiencies in sterile drug processing.